Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines
- PMID: 10347112
- DOI: 10.1002/hep.510290624
Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines
Abstract
Type I interferon (IFN) receptor consists of two chains (Hu-IFN-alphaR1 and Hu-IFN-alphaR2), and Hu-IFN-alphaR2 takes a soluble (Hu-IFN-alphaR2a), short (Hu-IFN-alphaR2b), or long (Hu-IFN-alphaR2c) form. We examined the expression of type I IFN receptor, the growth-suppression effect of IFN-alpha, and their relationship in 13 liver cancer cell lines. With reverse-transcription polymerase chain reaction (RT-PCR) analysis, the expressions of Hu-IFN-alphaR1, Hu-IFN-alphaR2a, and Hu-IFN-alphaR2c were confirmed in all cell lines, and that of Hu-IFN-alphaR2b in 12 cell lines. All cell lines expressed mRNAs of a transcriptional activator, interferon regulatory factor (IRF)-1, and its antagonistic repressor (IRF-2). Flow cytometry revealed weak expression of Hu-IFN-alphaR2 on the cell surface in 12 cell lines. The soluble-form protein of Hu-IFN-alphaR2 was detected at varying levels in culture supernatants of all cell lines with enzyme-linked immunosorbent assay (ELISA). Cell proliferation was suppressed in proportion to the dose of human natural IFN-alpha at 96 hours of culture, but it was not clearly related to the expression of Hu-IFN-alphaR2 protein on the cell surface. Investigations on the morphology, DNA, and cell cycle presented four growth suppression patterns as a result of IFN-alpha: 1) induction of apoptosis and blockage of cell cycle at the S phase (9 cell lines); 2) blockage at the S phase (2 cell lines); 3) induction of apoptosis and blockage at the G2/M phase (1 cell line); and 4) blockage at the G1 phase (1 cell line). There was no evidence showing that changes in the expressions of Bcl-2, Bcl-xL, Bak, and Bax lead directly to IFN-alpha-mediated apoptosis. Our findings demonstrated that IFN-alpha would express growth-suppression effects at varying degrees by inducing inhibition of cell-cycle progression with or without apoptosis, regardless of the expression level of Hu-IFN-alphaR2 protein on the cell surface.
Similar articles
-
Expression of Hu-IFN-alphaR2 chain of type I interferon receptor in human hepatocellular carcinoma and non-cancerous tissues.Int J Mol Med. 2000 Dec;6(6):621-7. doi: 10.3892/ijmm.6.6.621. Int J Mol Med. 2000. PMID: 11078820
-
Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.Clin Cancer Res. 2005 Feb 1;11(3):1277-86. Clin Cancer Res. 2005. PMID: 15709199
-
[Effect of hydroxyurea combined with interferon-alpha on growth and apoptosis-related oncogene expression of K562 cells].Zhonghua Yi Xue Za Zhi. 2000 Aug;80(8):606-9. Zhonghua Yi Xue Za Zhi. 2000. PMID: 11798827 Chinese.
-
The interferon receptors.Semin Oncol. 1997 Jun;24(3 Suppl 9):S9-18-S9-40. Semin Oncol. 1997. PMID: 9208871 Review.
-
Identification of functional type I and type II interferon receptors.Hokkaido Igaku Zasshi. 1994 Nov;69(6):1301-19. Hokkaido Igaku Zasshi. 1994. PMID: 7705745 Review.
Cited by
-
Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review.World J Hepatol. 2018 Sep 27;10(9):595-602. doi: 10.4254/wjh.v10.i9.595. World J Hepatol. 2018. PMID: 30310537 Free PMC article. Review.
-
Targeting type I interferons in systemic lupus erythematous.Front Pharmacol. 2023 Jan 16;13:1046687. doi: 10.3389/fphar.2022.1046687. eCollection 2022. Front Pharmacol. 2023. PMID: 36726783 Free PMC article. Review.
-
Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients.Cancers (Basel). 2021 Apr 6;13(7):1729. doi: 10.3390/cancers13071729. Cancers (Basel). 2021. PMID: 33917345 Free PMC article. Review.
-
Regulation of interferon signaling and HCV‑RNA replication by extracellular matrix.Int J Mol Med. 2018 Aug;42(2):957-965. doi: 10.3892/ijmm.2018.3693. Epub 2018 May 18. Int J Mol Med. 2018. PMID: 29786754 Free PMC article.
-
Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.Int J Clin Oncol. 2016 Aug;21(4):676-683. doi: 10.1007/s10147-015-0942-0. Epub 2015 Dec 23. Int J Clin Oncol. 2016. PMID: 26701173
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials